Citadel Advisors
VIVS

Citadel Advisors’s VivoSim Labs VIVS Stock Holding History

Citadel Advisors’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25
Closed -$657 – 15404
2023
Q1 		$657 Buy
+25
New +$597 ﹤0.01% 14444
2019
Q2 		– Sell
-54
Closed -$13K – 9988
2019
Q1 		$13K Sell
54
-78
-59% -$19.6K ﹤0.01% 9132
2018
Q4 		$30K Sell
132
-23
-15% -$5.79K ﹤0.01% 8621
2018
Q3 		$43K Buy
155
+90
+138% +$27.1K ﹤0.01% 8833
2018
Q2 		$22K Buy
65
+21
+48% +$6.92K ﹤0.01% 8630
2018
Q1 		$11K Sell
44
-140
-76% -$40.8K ﹤0.01% 8178
2017
Q4 		$59K Buy
184
+24
+15% +$8.92K ﹤0.01% 7584
2017
Q3 		$85K Buy
160
+21
+15% +$11.2K ﹤0.01% 7080
2017
Q2 		$88K Sell
139
-40
-22% -$26.9K ﹤0.01% 6952
2017
Q1 		$136K Sell
179
-39
-18% -$30.9K ﹤0.01% 6734
2016
Q4 		$178K Buy
218
+89
+69% +$70.6K ﹤0.01% 6388
2016
Q3 		$117K Buy
129
+11
+9% +$10.8K ﹤0.01% 6587
2016
Q2 		$106K Buy
+118
New +$79.1K ﹤0.01% 6164
2016
Q1 		– Sell
-93
Closed -$56K – 8157
2015
Q4 		$56K Sell
93
-154
-62% -$112K ﹤0.01% 7223
2015
Q3 		$159K Sell
247
-438
-64% -$333K ﹤0.01% 6437
2015
Q2 		$620K Buy
685
+569
+491% +$637K ﹤0.01% 4646
2015
Q1 		$99K Buy
116
+40
+53% +$55.2K ﹤0.01% 6846
2014
Q4 		$133K Sell
76
-77
-50% -$118K ﹤0.01% 6389
2014
Q3 		$234K Buy
153
+44
+40% +$79.8K ﹤0.01% 5560
2014
Q2 		$219K Sell
109
-127
-54% -$213K ﹤0.01% 5472
2014
Q1 		$433K Buy
236
+77
+48% +$179K ﹤0.01% 4559
2013
Q4 		$423K Buy
159
+138
+657% +$271K ﹤0.01% 4215
2013
Q3 		$29K Buy
+21
New +$29.3K ﹤0.01% 6053

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Citadel Advisors's VIVS Position: Q1 2026 in Review

Citadel Advisors sold out of VivoSim Labs (VIVS) in Q1 2026, closing a stake of 19,449 shares — an estimated $35.2K sold.

Citadel Advisors first reported a position in VIVS in Q4 2013 and held it in 29 quarters. The position peaked at $1.26M in Q3 2017. 24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

  • Citadel Advisors reported no remaining VivoSim Labs position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 19,449 VivoSim Labs shares in Q1 2026, an estimated $35.2K.
  • Citadel Advisors first reported a position in VivoSim Labs in Q4 2013 and held it in 29 quarters.
  • Citadel Advisors's VivoSim Labs position peaked at $1.26M in Q3 2017.
  • 24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.